Caution is advised in patients with a history of pancreatitis or severe gastrointestinal disease
FDAs own review staff recommended against adding all seven substances, citing an absence of human clinical evidence for several and, for BPC-157, studies that were small, uncontrolled or contradictory
S20), which was consistent with the results reported in the literature [46]
This does not change the reconstitution process, but it does mean the side effect profiles during dose escalation can differ
"Therapeutic potential of BPC-157 in nerve injury and repair." Peptides , 148, 170694.
Look up the active ingredients in the supplement